Ono Pharmaceutical Co., Ltd. (OPHLY)

Ono Pharmaceutical Revenue

Ono Pharmaceutical had revenue of 139.90B JPY in the quarter ending December 31, 2025, with 4.23% growth. This brings the company's revenue in the last twelve months to 509.35B, up 4.52% year-over-year. In the fiscal year ending March 31, 2025, Ono Pharmaceutical had annual revenue of 486.87B, down -3.14%.

• Revenue (ttm): 509.35B JPY
• Revenue Growth: +4.52%
• P/S Ratio: 2.36
• Revenue / Employee: 118.81M JPY
• Employees: 4,287
• Market Cap: 7.68B USD

Revenue Chart

* This company reports financials in JPY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	486.87B	-15.80B	-3.14%
Mar 31, 2024	502.67B	55.49B	12.41%
Mar 31, 2023	447.19B	85.83B	23.75%
Mar 31, 2022	361.36B	52.08B	16.84%
Mar 31, 2021	309.28B	16.86B	5.77%